tldrdaily.news logo
Tag

Breakthrough Therapy Designation

All articles tagged with #breakthrough therapy designation

healthcare2 years ago

Moderna aims to develop life-saving vaccines for cancer and heart disease by 2030.

Moderna plans to offer new vaccines targeting cancer, heart disease, and other conditions by 2030, according to the company's chief medical officer. Advancements in messenger RNA technology have opened up new possibilities for vaccines beyond infectious diseases like Covid-19. Moderna's personalized cancer vaccine, which received Breakthrough Therapy Designation from the FDA, is expected to be highly effective and save lives. The company is also developing a potential vaccine for respiratory syncytial virus (RSV), which received Breakthrough Therapy Designation and was found to be over 80% effective in preventing RSV symptoms in people over 60.

via CNBC|
#breakthrough-therapy-designation#cancer-vaccine#healthcare
health2 years ago

New pill shows promising results in treating leukemia patients.

An experimental pill called revumenib has completely eliminated cancer in a third of terminal leukaemia patients who were not responding to treatment, according to a clinical trial in the US. The drug inhibits a specific protein called menin, which is involved in the complex machinery that gets hijacked by leukaemia cells and causes normal blood cells to turn into cancerous ones. The drug works by reprogramming leukaemia cells back into normal cells. The US Food and Drug Administration granted revumenib "breakthrough therapy designation" to help fast-track its development and regulatory review.

via Euronews|
#breakthrough-therapy-designation#cancer#clinical-trial
health2 years ago

New Leukemia Drug Shows Promising Results in Clinical Trials.

An experimental pill called revumenib has completely eliminated cancer in a third of the participants in a clinical trial for acute myeloid leukaemia. The drug inhibits a specific protein called menin, which reprograms leukaemia cells back into normal cells. The US Food and Drug Administration has granted revumenib "breakthrough therapy designation" to fast-track its development and regulatory review. While the drug is not a definitive cure, researchers are optimistic about combining it with standard treatments to achieve cures for leukaemia patients.

via Euronews|
#breakthrough-therapy-designation#cancer#clinical-trial